Surface engineering of quantum dots for in vivo imaging

Area of Science:

• Nanotechnology
• Biomedical Engineering
• Materials Science

Background:

• Quantum dots (Qdots) are semiconductor nanoparticles with unique optical properties.
• Cysteamine-capped Qdots (amino-Qdots) have potential for bioimaging but exhibit unfavorable biodistribution.
• Surface modification is crucial for optimizing Qdot behavior in biological systems.

Purpose of the Study:

• To investigate the impact of gluconic acid (GA) conjugation on the in vivo biodistribution of cysteamine-capped quantum dots (amino-Qdots).
• To assess the effect of GA conjugation on the toxicity and optical properties of amino-Qdots.

Main Methods:

• Synthesis of Cadmium selenide/zinc sulfide (CdSe/ZnS) Qdots capped with cysteamine.
• Conjugation of gluconic acid to amino groups of cysteamine via amide bond formation.
• In vitro cytotoxicity assessment using CHO cells.
• In vivo biodistribution studies in mice with ex vivo optical imaging.

Main Results:

• GA-Qdots exhibited significantly lower cytotoxicity compared to amino-Qdots in CHO cells.
• Amino-Qdots predominantly accumulated in the lungs after intravenous injection.
• GA-Qdots demonstrated clearance through the kidneys, indicating altered biodistribution.
• Emission maxima were observed at 720 nm for Qdots, 600 nm for amino-Qdots, and 610 nm for GA-Qdots.

Conclusions:

• Gluconic acid conjugation effectively modifies the biodistribution of cysteamine-capped Qdots in vivo.
• GA-Qdots show reduced lung accumulation and renal clearance, suggesting improved safety and targeting potential.
• GA conjugation offers a promising strategy for developing amino-Qdots for in vivo imaging applications.